These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8796582)

  • 1. Inverse correlation between T1 relaxation times before and after administration of contrast media in malignant brain tumors.
    Niemi P; Aronen HJ; Kwong KK; Gazit IE; Pardo FS; Rosen BR
    Acad Radiol; 1996 Aug; 3 Suppl 2():S286-8. PubMed ID: 8796582
    [No Abstract]   [Full Text] [Related]  

  • 2. Spin-lock imaging in contrast-enhanced magnetic resonance imaging of human gliomas.
    Aronen HJ; Peltonen TK; Tanttu JI; Sipilä LM; Ruhala MT; Jääskeläinen J; Sepponen R
    Acad Radiol; 1996 Aug; 3 Suppl 2():S170-2. PubMed ID: 8796553
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
    Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Nguyen HD; Simonson TM
    J Magn Reson Imaging; 1994; 4(3):243-9. PubMed ID: 8061421
    [No Abstract]   [Full Text] [Related]  

  • 4. Macroscopic tumor volume of malignant glioma determined by contrast-enhanced magnetic resonance imaging with and without magnetization transfer contrast.
    Hawighorst H; Schreiber W; Knopp MV; Essig M; Engenhart-Cabilic R; Brix G; van Kaick G
    Magn Reson Imaging; 1996; 14(10):1119-26. PubMed ID: 9065901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
    Runge VM; Jacobson S; Wood ML; Kaufman D; Adelman LS
    Radiology; 1988 Mar; 166(3):835-8. PubMed ID: 3401296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
    Mihara F; Gupta KL; Righi AM
    Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.
    Bruening R; Kwong KK; Vevea MJ; Hochberg FH; Cher L; Harsh GR; Niemi PT; Weisskoff RM; Rosen BR
    AJNR Am J Neuroradiol; 1996 May; 17(5):831-40. PubMed ID: 8733954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic imaging of contrast enhancement in brain tumors.
    Bullock PR; Mansfield P; Gowland P; Worthington BS; Firth JL
    Magn Reson Med; 1991 Jun; 19(2):293-8. PubMed ID: 1881318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective enhancement of experimental rat brain tumors with Gd-TPPS.
    Bockhorst K; Els T; Hoehn-Berlage M
    J Magn Reson Imaging; 1994; 4(3):451-6. PubMed ID: 8061446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1 and T2 relaxation times on gadolinium-diethylenetriaminepentaacetic acid enhanced magnetic resonance images of brain tumors.
    Yamada S; Kubota R; Yamada K; Ono S; Hishinuma T; Matsuzawa T; Fujiwara S
    Tohoku J Exp Med; 1990 Feb; 160(2):145-8. PubMed ID: 2353348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of hyperventilation for improving the visualization of glial tumors of the brain in magnetic resonance tomography using the contrast substance Gd-DTPA].
    Pronin IN; Kornienko VN; Petriaĭkin AV; Golanov AV
    Zh Vopr Neirokhir Im N N Burdenko; 1995; (3):10-3. PubMed ID: 7483947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
    Hoehn-Berlage M; Bockhorst K
    Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of gadolinium administration in magnetic resonance imaging screening of patients with complex partial seizures and results of a normal neurologic examination.
    Sanders WP; Silbergleit R; Spickler EM; Barkley GL; Mehta BA
    Invest Radiol; 1995 Nov; 30(11):634-7. PubMed ID: 8557503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination.
    Rippe DJ; Boyko OB; Fuller GN; Friedman HS; Oakes WJ; Schold SC
    AJNR Am J Neuroradiol; 1990; 11(4):800-1. PubMed ID: 2114771
    [No Abstract]   [Full Text] [Related]  

  • 15. MRI characterization of 9L-glioma in rat brain at 4.7 Tesla.
    Rajan SS; Rosa L; Francisco J; Muraki A; Carvlin M; Tuturea E
    Magn Reson Imaging; 1990; 8(2):185-90. PubMed ID: 2338899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetization transfer contrast in Gd-DTPA-enhanced imaging of brain tumors.
    Niemi P; Kurki T; Lundbom N; Kormano M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S248-9; discussion S253-4. PubMed ID: 1808140
    [No Abstract]   [Full Text] [Related]  

  • 17. [Double-dose Gd-DTPA: detectability of intraparenchymal brain metastasis].
    Tatsuno S; Hata Y; Tada S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Oct; 56(12):855-9. PubMed ID: 8940816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental trials with Gd(DO3A)--a nonionic magnetic resonance contrast agent.
    Runge VM; Kaufman DM; Wood ML; Adelman LS; Jacobson S
    Int J Rad Appl Instrum B; 1989; 16(6):561-7. PubMed ID: 2606711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium-enhanced MRI of intracranial lesions. A review of indications and results.
    Wilms G; Marchal G; Demaerel PH; Van Hecke P; Baert AL
    Clin Imaging; 1991; 15(3):153-65. PubMed ID: 1933642
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of T1 time course changes and tissue-blood ratios after Gd-DTPA administration in brain tumors.
    Yoshida K; Furuse M; Kaneoke Y; Saso K; Inao S; Motegi Y; Ichihara K; Izawa A
    Magn Reson Imaging; 1989; 7(1):9-15. PubMed ID: 2918823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.